Braest cancer

Clinical trials for Braest cancer explained in plain language.

Never miss a new study

Get alerted when new Braest cancer trials appear

Sign up with your email to follow new studies for Braest cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Two-Drug combo aims to stall advanced breast cancer

Disease control Recruiting now

Researchers are testing whether dalpiciclib, a targeted cancer drug, combined with toremifene, a hormonal therapy, can slow the growth of advanced HR-positive, HER2-negative breast cancer when used as a first-line treatment. The trial plans to enroll 36 women who have not yet rec…

Matched conditions: BRAEST CANCER

Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Braest cancer

Get alerted when new Braest cancer trials appear

Two-Drug combo aims to stall advanced breast cancer